SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results

Core Insights - SIGA Technologies, Inc. is hosting a business update webcast and conference call on November 6, 2025, at 4:30 P.M. ET [1] - The call will feature CEO Diem Nguyen and CFO Daniel Luckshire [1] Company Overview - SIGA is a commercial-stage pharmaceutical company focused on developing innovative medicines for infectious diseases, particularly orthopoxviruses [4] - The company aims to protect against severe infectious diseases through partnerships with governments and public health agencies [4] - SIGA's flagship product, TPOXX® (tecovirimat), is approved in the U.S. and Canada for smallpox treatment and authorized in Europe, the UK, and Japan for smallpox, mpox, cowpox, and vaccinia complications [4]